ONSWIK FDA approval date

The FDA approved ONSWIK on 23 Sep 2026.

FDA approval date
23 Sep 2026

Drug identity has not yet been verified against registry records

Also recorded as INSULIN EFSITORA ALFA-GOBE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-09-23DayONSWIKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761408", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["ONSWIK"], "active_ingredients": ["INSULIN EFSITORA ALFA-GOBE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260923", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026